Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Reviving A Longsuffering Neuro Company: The Marinus Story

Oct 24 2022

• By Jo Shorthouse

Phoenix flying high — Marinus' phoenix has now risen from the ashes • Source: Shutterstock

Related Content

Marinus Charts The Way Forward For Ganaxolone Amid Business Challenges

Jul 24 2019

Rare Genetic Epilepsy Responsive To Marinus's Ganaxolone

Sep 15 2020

After Years Of Setbacks, Marinus Closes In On Rare Epilepsy Opportunity

Aug 04 2021

Related Companies

Marinus Pharmaceuticals, Inc.

Pacira BioSciences, Inc.

Sage Therapeutics, Inc.

Additional Topics

Strategy Restructuring Leadership Innovation Business Strategies Companies Growth Pediatrics Rare Diseases Research & Development Neurology BioPharmaceutical C-Suite Speaks

More from Leadership

More from In Vivo

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.